[Role of the adrenergic mechanisms in the action of drugs on the cardiovascular system].
D000262:Adenylyl Cyclases / Q000502:physiology; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D005246:Feedback; D006801:Humans; D008750:Methyldopa / Q000494:pharmacology; D008995:Monoamine Oxidase / Q000502:physiology; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000201:enzymology; D009474:Neurons / Q000502:physiology; D013564:Sympathetic Nervous System / Q000502:physiology; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D013565:Sympatholytics; D013566:Sympathomimetics; D008750:Methyldopa; D008995:Monoamine Oxidase; D000262:Adenylyl Cyclases
Rola mechanizmów adrenergicznych w działaniu leków na układ krazenia